Strategic Partnerships Opportunity to leverage collaborations with KITSS Therapeutics to accelerate market access in Africa, specifically Ghana and Liberia, expanding BloodSTOP iX adoption in regional healthcare markets.

EMS and Surgery Strong traction in EMS prehospital care and surgical settings including burn and trauma surgeries presents a clear pathway for expanded procurement with emergency medical services, hospitals, and surgical centers.

Chronic Wound Focus Target diabetic ulcers and decubitus (pressure) wounds in hospital systems and long-term care facilities where advanced hemostatic and wound care solutions can reduce complications and shorten healing times.

Global Expansion Recent international product introductions and trademark actions suggest a readiness to scale distribution; pursue distributor partnerships and regional clinical education programs to fuel growth.

Brand and IP Leverage BloodSTOP iX Advanced Hemostat and WoundHEAL branding in pitches to healthcare networks, highlighting patented technology and differentiated performance to win new tenders and device supplier contracts.